Welcome to the investors section of Adocia
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
- 2020/11/06Number of shares and voting rights of ADOCIA as of October 31, 2020
- 2020/10/20Adocia Announces Third Quarter 2020 Financial Results
- January 13-16, 2021 38th Annual J.P. Morgan Healthcare Conference. Virtual Event